Authors
Loading...
BioLab automates end-to-end biological research using a multi-agent approach, suggesting breakthroughs in antibody design.
Jin et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: